Nexalin Technology logo
Nexalin Technology
NXL | NASDAQ
Chart Builder DCF Calculator
$1.56
+$0.08 (+5.41%)
At close: Nov 16, 2026, 4:00 PM ET
$1.54
-$0.02 (-1.28%)
After-hours: Nov 16, 2026, 6:00 PM ET

Nexalin Technology Company Profile

Company profile explained

Company Profile

Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders. Furthermore, Nexalin Technology is currently developing "Generation 2," a new medical device undergoing clinical trials. This future product aims to address a broader spectrum of health issues, including opiate addiction, persistent pain, Alzheimer's disease, and dementia. The company was founded in 2021 and has its headquarters in Houston, Texas.

Key Executives

Name Position
Mark White President, Chief Executive Officer & Director
Justin Van Fleet Chief Financial Officer
Carolyn Shelton Executive Vice President of Clinical, Quality & Regulatory Affairs
David Owens Chief Medical Officer, Member of Scientific Advisory Board & Director
John Patrick Claude Co-Founder and Director of Engineering & Development

Latest SEC Filings

Date Type Title
Oct 27, 2026 PRE 14A Filing
Oct 15, 2026 EFFECT Filing
Oct 08, 2026 S-1/A [Amend] Filing
Oct 01, 2026 8-K Current Report
Oct 01, 2026 8-K Current Report
Sep 28, 2026 8-K Current Report
Sep 22, 2026 S-8 Filing
Sep 03, 2026 S-1 Filing
Sep 03, 2026 SC 13D Filing
Sep 02, 2026 8-K Current Report
View All SEC Filings ➞
Nexalin Technology
Nexalin Technology logo
Country United States
IPO Date Sep 16, 2022
Industry Medical - Devices
Sector Healthcare
Employees 8
CEO Mark White

Contact Details

1776 Yorktown Houston, Texas 77056 United States

Stock Details

Ticker Symbol NXL
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001527352
CUSIP Number 65345B300
ISIN Number US65345B3006
SIC Code 3845

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.